The last two years have been tumultuous. A virus turned the world on its head and in doing so, revealed areas where we, as a global partner to and diagnostics enterprises fighting this pandemic, can improve in speed and scale.
The COVID-19 pandemic itself did not come as a surprise. Pandemic preparedness plans existed. Countries already had experience managing local outbreaks of worrisome diseases like Ebola, MERS, and SARS. What caught the world off guard, however, was the sheer speed and magnitude of the crisis.
This health challenge was far bigger than anyone expected, and the prospect of a global population held hostage not only to a virus but to the paralysis of international structures was frightening. Like everywhere else, things changed dramatically at Roche CustomBiotech. Uncertainty made sustained business difficult. However, our mandate was clear: rise to the challenge and stand by our customers at the frontline.